Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.
肿瘤免疫微环境中cGAS-STING信号通路的细胞间信号传递.
Cell-to-cell communication
Double stranded DNA
Immune responses
Review
Tumor immunity
Tumor microenvironment
cGAS-STING
Journal
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
ISSN: 1008-9292
Titre abrégé: Zhejiang Da Xue Xue Bao Yi Xue Ban
Pays: China
ID NLM: 100927946
Informations de publication
Date de publication:
12 Jan 2024
12 Jan 2024
Historique:
medline:
4
3
2024
pubmed:
17
1
2024
entrez:
17
1
2024
Statut:
epublish
Résumé
Targeting cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS)-stimulator of interferon genes (STING) pathway is a promising strategy for tumor treatment. The pattern recognition receptor cGAS identifies dsDNA and catalyzes the formation of a second messenger 2'3'-cyclic guanosine monophosphate-adenosine monophosphate (cGAMP), activating the downstream interferons and pro-inflammatory cytokines through the adaptor protein STING. Notably, in tumor immune microenvironment, key components of cGAS-STING pathway are transferred among neighboring cells. The intercellular transmission under these contexts serves to sustain and amplify innate immune responses while facilitating the emergence of adaptive immunity. The membrane-based system, including extracellular vesicles transport, phagocytosis and membrane fusion transmit dsDNA, cGAMP and activated STING, enhances the immune surveillance and inflammatory responses. The membrane proteins, including a specific protein channel and intercellular gap junctions, transfer cGAMP and dsDNA, which are crucial to regulate immune responses. The ligand-receptor interactions for interferon transmission amplifies the anti-tumor response. This review elaborates on the regulatory mechanisms of cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment, explores how these mechanisms modulate immunological processes and discusses potential interventions and immunotherapeutic strategies targeting these signaling cascades. 环鸟苷酸-腺苷酸合成酶(cGAS)-干扰素基因刺激因子(STING)信号通路是肿瘤免疫治疗中备受关注的靶点。模式识别受体cGAS识别胞质双链DNA(dsDNA),生成第二信使2 ´ 3 ´-环鸟苷酸-腺苷酸(cGAMP),活化接头蛋白STING,介导干扰素和促炎性细胞因子的产生,从而促进肿瘤免疫。肿瘤免疫微环境中cGAS-STING通路的细胞间信号传递维持并增强天然免疫应答,推动适应性免疫的发展。基于膜系统的细胞外囊泡运输、吞噬作用和细胞膜融合传递dsDNA、cGAMP以及活化的STING蛋白,加强免疫监视和炎症应答。基于膜蛋白的缝隙连接、膜转运蛋白传递cGAMP和dsDNA对免疫调节至关重要。此外,配体-受体反应传递干扰素进一步放大抗肿瘤免疫反应。本文描述了肿瘤免疫微环境中cGAS-STING通路的细胞间信号传递及其调控,讨论这些机制如何影响和调节肿瘤免疫过程,以及针对这些信号传递机制的潜在干预和免疫治疗策略。.
Autres résumés
Type: Publisher
(chi)
环鸟苷酸-腺苷酸合成酶(cGAS)-干扰素基因刺激因子(STING)信号通路是肿瘤免疫治疗中备受关注的靶点。模式识别受体cGAS识别胞质双链DNA(dsDNA),生成第二信使2 ´ 3 ´-环鸟苷酸-腺苷酸(cGAMP),活化接头蛋白STING,介导干扰素和促炎性细胞因子的产生,从而促进肿瘤免疫。肿瘤免疫微环境中cGAS-STING通路的细胞间信号传递维持并增强天然免疫应答,推动适应性免疫的发展。基于膜系统的细胞外囊泡运输、吞噬作用和细胞膜融合传递dsDNA、cGAMP以及活化的STING蛋白,加强免疫监视和炎症应答。基于膜蛋白的缝隙连接、膜转运蛋白传递cGAMP和dsDNA对免疫调节至关重要。此外,配体-受体反应传递干扰素进一步放大抗肿瘤免疫反应。本文描述了肿瘤免疫微环境中cGAS-STING通路的细胞间信号传递及其调控,讨论这些机制如何影响和调节肿瘤免疫过程,以及针对这些信号传递机制的潜在干预和免疫治疗策略。.
Identifiants
pubmed: 38229499
doi: 10.3724/zdxbyxb-2023-0482
doi:
Substances chimiques
Adaptor Proteins, Signal Transducing
0
Cytokines
0
Interferons
9008-11-1
Types de publication
Review
Journal Article
Langues
eng
chi
Sous-ensembles de citation
IM
Pagination
15-24Références
J Immunother Cancer. 2020 Dec;8(2):
pubmed: 33268351
Science. 2020 Feb 21;367(6480):
pubmed: 32079747
Mol Cell. 2021 Oct 21;81(20):4147-4164.e7
pubmed: 34453890
Nature. 2019 Mar;567(7747):262-266
pubmed: 30842662
Mol Cell. 2019 Jul 25;75(2):372-381.e5
pubmed: 31126740
Drug Deliv. 2020 Dec;27(1):585-598
pubmed: 32264719
Nature. 2016 May 18;533(7604):493-498
pubmed: 27225120
Science. 2015 Sep 11;349(6253):1228-32
pubmed: 26229117
Br J Cancer. 2023 Feb;128(3):461-467
pubmed: 36068276
Cell Res. 2022 Dec;32(12):1086-1104
pubmed: 36280710
Cancer Biol Med. 2023 Mar 2;20(2):
pubmed: 36861445
Clin Cancer Res. 2023 Jun 13;29(12):2184-2193
pubmed: 36719675
Cancer Discov. 2021 May;11(5):1212-1227
pubmed: 33372007
Nature. 2015 Apr 23;520(7548):553-7
pubmed: 25642965
Biomed Pharmacother. 2020 Mar;123:109790
pubmed: 31896065
J Virol. 2021 Feb 24;95(6):
pubmed: 33361424
Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4612-E4620
pubmed: 28533362
Mol Cell. 2022 Dec 1;82(23):4519-4536.e7
pubmed: 36384137
Nat Cancer. 2022 Dec;3(12):1452-1463
pubmed: 36510011
ACS Cent Sci. 2021 Jun 23;7(6):1073-1088
pubmed: 34235268
Cell Host Microbe. 2016 Oct 12;20(4):443-457
pubmed: 27736643
Cell Death Dis. 2021 Aug 27;12(9):815
pubmed: 34453041
Nat Rev Immunol. 2021 Sep;21(9):548-569
pubmed: 33833439
J Exp Med. 2018 May 7;215(5):1287-1299
pubmed: 29622565
Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2214278119
pubmed: 36442099
Blood. 2012 Nov 1;120(18):3699-707
pubmed: 22927244
Proc Natl Acad Sci U S A. 2022 May 24;119(21):e2119189119
pubmed: 35588451
Science. 2023 Aug 4;381(6657):508-514
pubmed: 37535724
Nat Cell Biol. 2022 May;24(5):766-782
pubmed: 35501370
Mol Cell. 2020 Nov 19;80(4):578-591.e5
pubmed: 33171122
Nature. 2017 Aug 24;548(7668):461-465
pubmed: 28738408
Immunity. 2022 Feb 8;55(2):308-323.e9
pubmed: 34800368
Immunity. 2020 Feb 18;52(2):357-373.e9
pubmed: 32049051
Nature. 2022 Oct;610(7931):373-380
pubmed: 36198789
Immunity. 2020 May 19;52(5):767-781.e6
pubmed: 32277911
J Hematol Oncol. 2021 Sep 3;14(1):136
pubmed: 34479611
Cell. 2013 May 23;153(5):1094-107
pubmed: 23647843
Microbiol Mol Biol Rev. 2007 Jun;71(2):398-411
pubmed: 17554050
Immunity. 2019 Apr 16;50(4):907-923
pubmed: 30995506
Cell Chem Biol. 2020 Nov 19;27(11):1347-1358.e5
pubmed: 32726585
J Extracell Vesicles. 2023 Mar;12(3):e12316
pubmed: 36946680
Nat Med. 2015 Oct;21(10):1209-15
pubmed: 26322579
J Biol Chem. 2014 Nov 7;289(45):30880-8
pubmed: 25281745
Oncoimmunology. 2020 Jun 16;9(1):1777624
pubmed: 32934881
Nat Cell Biol. 2017 Sep;19(9):1061-1070
pubmed: 28759028
Nat Immunol. 2016 Sep 20;17(10):1142-9
pubmed: 27648547
Curr Oncol Rep. 2023 Mar;25(3):189-199
pubmed: 36705879
Nature. 2019 Sep;573(7774):434-438
pubmed: 31511694
Nature. 2013 Nov 28;503(7477):530-4
pubmed: 24077100
Eur J Immunol. 2023 Sep;53(9):e2350386
pubmed: 37424054
Trends Cell Biol. 2023 Aug;33(8):630-648
pubmed: 36437149
Cell Rep. 2022 May 31;39(9):110880
pubmed: 35649354
J Control Release. 2017 Sep 28;262:247-258
pubmed: 28687495
Immunity. 2022 Oct 11;55(10):1799-1812.e4
pubmed: 36070769
Science. 2018 Aug 17;361(6403):704-709
pubmed: 29976794
Nat Microbiol. 2019 Apr;4(4):701-713
pubmed: 30804548
Chem Rev. 2022 Mar 23;122(6):5977-6039
pubmed: 35107989
Mol Cancer. 2022 Jan 21;21(1):28
pubmed: 35062949
mBio. 2020 Jan 28;11(1):
pubmed: 31992625
Trends Cell Biol. 2023 Mar;33(3):189-203
pubmed: 35931610
Nature. 2017 Oct 19;550(7676):402-406
pubmed: 28976970
Nature. 2019 Jan;565(7741):659-663
pubmed: 30675059
Nat Rev Drug Discov. 2022 May;21(5):379-399
pubmed: 35236964